Efficacy and Safety of Clarithromycin as Treatment for Mediterranean Spotted Fever in Children: A Randomized Controlled Trial
Open Access
- 1 August 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (3) , 409-411
- https://doi.org/10.1086/321864
Abstract
Fifty-one children with Mediterranean spotted fever (MSF) were randomized to receive either clarithromycin, 15 mg/kg/day orally in 2 divided doses, oKeywords
This publication has 10 references indexed in Scilit:
- In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayersJournal of Antimicrobial Chemotherapy, 2000
- In Vitro Susceptibilities of 27 Rickettsiae to 13 AntimicrobialsAntimicrobial Agents and Chemotherapy, 1998
- Clinical and laboratory findings of boutonneuse fever in Sicilian childrenEuropean Journal of Pediatrics, 1998
- Rickettsioses as paradigms of new or emerging infectious diseasesClinical Microbiology Reviews, 1997
- In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayersAntimicrobial Agents and Chemotherapy, 1997
- Azithromycin vs. Doxycycline for Mediterranean Spotted FeverThe Pediatric Infectious Disease Journal, 1996
- Mediterranean spotted fever in Marseille: Descriptive epidemiology and the influence of climatic factorsEuropean Journal of Epidemiology, 1992
- Randomized trial of doxycycline versus josamycin for Mediterranean spotted feverAntimicrobial Agents and Chemotherapy, 1990
- Imported rickettsial disease: clinical and epidemiologic featuresThe American Journal of Medicine, 1988
- Erythromycin versus tetracycline for treatment of Mediterranean spotted fever.Archives of Disease in Childhood, 1986